ConductScience.org, home

Paper393288

Treatment of severe hypertension by repeated bolus injections of labetalol.

Cumming AM and 4 others. Br J Clin Pharmacol, 1979. Cited by 22 papers, by iCite.

Cite this record

ConductScience Library. Treatment of severe hypertension by repeated bolus injections of labetalol. Papers, record 393288. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/393288

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Treatment of severe hypertension by repeated bolus injections of labetalol.
PubMed
Journal
Br J Clin Pharmacol
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
22
iCite
Relative citation ratio, by iCite
1.77
iCite
Revised in PubMed
2018-11-13
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cumming AMA M
2Brown JJJ J
3Lever AFA F
4Mackay AA
5Robertson JIJ I

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
EthanolaminesMajor topic
HypertensionMajor topic
LabetalolMajor topic
Adolescent
Adult
Aged
Angiotensin II
Blood Pressure
Creatinine
Female
Humans
Hypertension, Malignant
Injections, Intravenous
Male
Middle Aged
Renin

Source PubMed

Download CSV of topics

References9

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
113849070The electrocardiogram in population studies. A classification system.Circulation1960https://conductscience.org/library/papers/13849070PubMed
2667883Management of complicated hypertension including hypertensive emergencies.Cardiovasc Clin1978https://conductscience.org/library/papers/667883PubMed
368239Labetalol in hypertension.Lancet1977https://conductscience.org/library/papers/68239PubMed
425757Labetalol: a review of its pharmacology and therapeutic use in hypertension.Drugs1978https://conductscience.org/library/papers/25757PubMed
54692673Autoregulation of brain circulation in severe arterial hypertension.Br Med J1973https://conductscience.org/library/papers/4692673PubMed
6990152Metabolism of labetalol by animals and man.Br J Clin Pharmacol1976https://conductscience.org/library/papers/990152PubMed
74333501Estimation of angiotensin II concentration in human plasma by radioimmunoassay. Some applications to physiological and clinical states.Eur J Clin Invest1971https://conductscience.org/library/papers/4333501PubMed
84425852Ischaemic heart disease in young women.Br Med J1974https://conductscience.org/library/papers/4425852PubMed
9791333Effect of blood pressure angiotensin II and aldosterone concentrations during treatment of severe hypertension with intravenous labetalol: comparison with propranolol.Br J Clin Pharmacol1976https://conductscience.org/library/papers/791333PubMed

Download CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.

PMIDTitleJournalYearIn PapersSource
7093106Intravenous labetalol in severe hypertension.Br J Clin Pharmacol1982https://conductscience.org/library/papers/7093106PubMed
6653648Diazoxide and labetalol in acute hypertension during haemodialysis.Eur J Clin Pharmacol1983https://conductscience.org/library/papers/6653648PubMed
6151891Combined alpha- and beta-receptor inhibition in the treatment of hypertension.Drugs1984https://conductscience.org/library/papers/6151891PubMed
6151890Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.Drugs1984https://conductscience.org/library/papers/6151890PubMed
6147240Hypertension in pregnancy. Pathophysiology and management.Drugs1984https://conductscience.org/library/papers/6147240PubMed
6124265Comparison of labetalol with other anti-hypertensive drugs.Br J Clin Pharmacol1982https://conductscience.org/library/papers/6124265PubMed
3123620Hypertensive emergencies and urgencies: definition, recognition, and management.J Gen Intern Med1988https://conductscience.org/library/papers/3123620PubMed
2770185[Effectiveness and hemodynamic mechanism of action of blood pressure lowering by intravenous labetalol in patients with a critical increase in blood pressure].Klin Wochenschr1989https://conductscience.org/library/papers/2770185PubMed
526408Labetalol, an alpha- and beta-adrenoceptor-blocking agent: its use in therapeutics. A summary of the symposium.Br J Clin Pharmacol1979https://conductscience.org/library/papers/526408PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/393288

GET https://conductscience.org/api/papers/v1/393288/authors